Single Oral Doses of MK-8507, a Novel Non-Nucleoside Reverse Transcriptase Inhibitor, Suppress HIV-1 RNA for a Week
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Single Oral Doses of MK-8507, a Novel Non-Nucleoside Reverse Transcriptase Inhibitor, Suppress HIV-1 RNA for a Week
Authors
Keywords
-
Journal
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
Volume 89, Issue 2, Pages 191-198
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2021-10-20
DOI
10.1097/qai.0000000000002834
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparison of Overall and Comorbidity-Free Life Expectancy Between Insured Adults With and Without HIV Infection, 2000-2016
- (2020) Julia L. Marcus et al. JAMA Network Open
- Prevalence of doravirine-associated resistance mutations in HIV-1-infected antiretroviral-experienced patients from two large databases in France and Italy
- (2019) Cathia Soulie et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The Role of Stigma Management in HIV Treatment Adherence
- (2019) Lance Rintamaki et al. International Journal of Environmental Research and Public Health
- OUP accepted manuscript
- (2018) CLINICAL INFECTIOUS DISEASES
- HIV in practice: current approaches and challenges in the diagnosis, treatment and management of HIV infection in Australia
- (2018) DE Smith et al. HIV MEDICINE
- Improving the Adherence to Antiretroviral Therapy, a Difficult but Essential Task for a Successful HIV Treatment—Clinical Points of View and Practical Considerations
- (2017) Simona A. Iacob et al. Frontiers in Pharmacology
- Systematic review to determine the prevalence of transmitted drug resistance mutations to rilpivirine in HIV-infected treatment-naive persons
- (2016) Vincent Calvez et al. ANTIVIRAL THERAPY
- Characterizing Class-Specific Exposure-Viral Load Suppression Response of HIV Antiretrovirals Using A Model-Based Meta-Analysis
- (2016) Y Xu et al. CTS-Clinical and Translational Science
- Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors
- (2016) William Polonsky et al. Patient Preference and Adherence
- Patient-Reported Barriers to Adherence to Antiretroviral Therapy: A Systematic Review and Meta-Analysis
- (2016) Zara Shubber et al. PLOS MEDICINE
- Adherence to GLP-1 receptor agonist therapy administered by once-daily or once-weekly injection in patients with type 2 diabetes in Germany
- (2016) Karel Kostev et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- The evolution of three decades of antiretroviral therapy: challenges, triumphs and the promise of the future
- (2015) Alice Tseng et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Systematic Literature Review and Meta-analysis of Medication Adherence With Once-weekly Versus Once-daily Therapy
- (2015) Kristy Iglay et al. CLINICAL THERAPEUTICS
- Current state and limitations of daily oral therapy for treatment
- (2015) Daniel A. Solomon et al. Current Opinion in HIV and AIDS
- The end of AIDS: HIV infection as a chronic disease
- (2013) Steven G Deeks et al. LANCET
- Novel Method To Assess Antiretroviral Target Trough Concentrations UsingIn VitroSusceptibility Data
- (2012) Edward P. Acosta et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics and Pharmacodynamics of Once-Daily versus Twice-Daily Raltegravir in Treatment-Naïve HIV-Infected Patients
- (2012) Matthew L. Rizk et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Genotypic and Phenotypic Characterization of HIV-1 Isolates Obtained From Patients on Rilpivirine Therapy Experiencing Virologic Failure in the Phase 3 ECHO and THRIVE Studies
- (2011) Laurence Rimsky et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started